Tuberculosis endotypes to guide stratified host-directed therapy.


Journal

Med (New York, N.Y.)
ISSN: 2666-6340
Titre abrégé: Med
Pays: United States
ID NLM: 101769215

Informations de publication

Date de publication:
12 03 2021
Historique:
entrez: 25 10 2021
pubmed: 26 10 2021
medline: 26 10 2021
Statut: ppublish

Résumé

There is hope that host-directed therapy (HDT) for Tuberculosis (TB) can either shorten treatment duration, help cure drug resistant disease or limit the immunopathology. Many candidate HDT drugs have been proposed, however solid evidence only exists for a few select patient groups. The clinical presentation of TB is variable, with differences in severity, tissue pathology, and bacillary burden. TB clinical phenotypes likely determine the potential benefit of HDT. Underlying TB clinical phenotypes, there are TB "endotypes," defined as distinct molecular profiles, with specific metabolic, epigenetic, transcriptional, and immune phenotypes. TB endotypes can be characterized by either immunodeficiency or pathologic excessive inflammation. Additional factors, like comorbidities (HIV, diabetes, helminth infection), structural lung disease or

Identifiants

pubmed: 34693385
doi: 10.1016/j.medj.2020.11.003
pmc: PMC8530349
mid: NIHMS1739847
doi:

Substances chimiques

Antitubercular Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Pagination

217-232

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI137527
Pays : United States
Organisme : NIEHS NIH HHS
ID : P42 ES027725
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI104960
Pays : United States
Organisme : NIAID NIH HHS
ID : K23 AI141681
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES030285
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA125123
Pays : United States

Références

Front Cell Infect Microbiol. 2019 Oct 04;9:342
pubmed: 31637222
J Clin Invest. 2015 May;125(5):1827-38
pubmed: 25822019
Clin Cancer Res. 2017 Jul 1;23(13):3334-3342
pubmed: 28073839
Chest. 2018 Jun;153(6):1292-1293
pubmed: 29884247
J Infect Dis. 2008 Dec 15;198(12):1842-50
pubmed: 18954258
Am J Respir Crit Care Med. 2016 Aug 1;194(3):345-55
pubmed: 26882070
J Infect Dis. 2013 Aug 15;208(4):603-15
pubmed: 23661793
J Exp Med. 2008 Nov 24;205(12):2791-801
pubmed: 18955568
PLoS Comput Biol. 2019 Mar 5;15(3):e1006701
pubmed: 30835723
Immunity. 2016 Feb 16;44(2):368-79
pubmed: 26885859
Nature. 2019 Mar;567(7749):530-534
pubmed: 30814732
Nat Rev Microbiol. 2014 Apr;12(4):289-99
pubmed: 24590243
Eur J Clin Microbiol Infect Dis. 2018 Feb;37(2):371-380
pubmed: 29189980
J Exp Med. 2018 Apr 2;215(4):1035-1045
pubmed: 29511063
Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12410-12415
pubmed: 31152140
Nat Rev Immunol. 2001 Oct;1(1):20-30
pubmed: 11905811
Cell. 2017 Jun 29;170(1):142-157.e19
pubmed: 28648661
Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):E2776-E2785
pubmed: 28283662
Int J Tuberc Lung Dis. 2014 Apr;18(4):492-8
pubmed: 24670708
Immunity. 2017 Jun 20;46(6):1089-1090
pubmed: 28636957
Cell Commun Signal. 2013 Aug 19;11:60
pubmed: 23958185
N Engl J Med. 2012 Aug 23;367(8):725-34
pubmed: 22913682
Am J Respir Crit Care Med. 2014 Dec 15;190(12):1430-6
pubmed: 25390734
Infect Immun. 2007 Feb;75(2):820-9
pubmed: 17145950
Lancet Respir Med. 2020 Apr;8(4):395-406
pubmed: 31958400
J Clin Invest. 2018 May 1;128(5):1837-1851
pubmed: 29461976
PLoS One. 2010 Mar 22;5(3):e9753
pubmed: 20339534
Front Immunol. 2020 May 12;11:891
pubmed: 32477361
PLoS Pathog. 2011 Mar;7(3):e1001307
pubmed: 21408618
Nature. 2016 Dec 8;540(7632):236-241
pubmed: 27798602
J Immunol. 2003 Jan 1;170(1):597-603
pubmed: 12496448
Trends Immunol. 2018 Jan;39(1):6-18
pubmed: 28923365
J Diabetes Res. 2016;2016:6014631
pubmed: 27057552
Chest. 2017 Jul;152(1):174-180
pubmed: 28434937
J Clin Invest. 2020 Jun 1;130(6):3113-3123
pubmed: 32125282
Cell. 2012 Feb 3;148(3):434-46
pubmed: 22304914
Clin Infect Dis. 2018 Jan 6;66(2):198-205
pubmed: 29325084
Nat Commun. 2020 Jun 9;11(1):2917
pubmed: 32518235
J Clin Med. 2019 Dec 16;8(12):
pubmed: 31888124
Expert Rev Clin Immunol. 2010 Jan;6(1):137-54
pubmed: 20383897
Immunity. 2016 Aug 16;45(2):358-73
pubmed: 27496729
J Infect Dis. 2019 Jun 5;220(1):139-150
pubmed: 30753544
Semin Immunol. 2014 Dec;26(6):454-70
pubmed: 25453225
Nature. 2018 Aug;560(7720):644-648
pubmed: 30135583
Nat Med. 2011 Mar;17(3):372-6
pubmed: 21336285
PLoS Pathog. 2019 Apr 18;15(4):e1007724
pubmed: 30998773
Epigenetics. 2008 May-Jun;3(3):149-56
pubmed: 18567946
Nat Rev Drug Discov. 2018 Jan;17(1):35-56
pubmed: 28935918
mBio. 2016 May 31;7(3):
pubmed: 27247233
Nat Med. 2018 Nov;24(11):1708-1715
pubmed: 30397355
Nat Rev Immunol. 2019 Jul;19(7):417-432
pubmed: 30918351
Clin Infect Dis. 2008 Sep 1;47(5):634-41
pubmed: 18652554
Trends Microbiol. 2017 Aug;25(8):688-697
pubmed: 28366292
Elife. 2020 Feb 24;9:
pubmed: 32091388
Science. 1998 May 29;280(5368):1435-8
pubmed: 9603733
Eur J Immunol. 2003 Dec;33(12):3393-7
pubmed: 14635048
N Engl J Med. 2018 Nov 15;379(20):1915-1925
pubmed: 30428290
Immunity. 2017 Dec 19;47(6):1129-1141.e5
pubmed: 29246443
Ann Rheum Dis. 2003 Nov;62 Suppl 2:ii37-42
pubmed: 14532147
Curr Opin Allergy Clin Immunol. 2018 Jun;18(3):184-189
pubmed: 29601354
Am J Epidemiol. 2009 Dec 15;170(12):1478-85
pubmed: 19917554
Jpn J Microbiol. 1975 Jun;19(3):235-6
pubmed: 809612
J Immunol. 2013 Apr 15;190(8):3959-66
pubmed: 23509356
Infect Immun. 2004 Sep;72(9):5511-4
pubmed: 15322056
Respirology. 2010 Apr;15(3):433-50
pubmed: 20415982
Cell. 2017 May 4;169(4):570-586
pubmed: 28475890
J Immunol. 2018 Jul 1;201(1):124-133
pubmed: 29752313
Lancet Infect Dis. 2013 May;13(5):436-48
pubmed: 23531392
Nat Genet. 2007 Apr;39(4):523-8
pubmed: 17322885
Lung India. 2015 Nov-Dec;32(6):593-601
pubmed: 26664166
Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):270-5
pubmed: 9419365
Front Immunol. 2019 May 09;10:996
pubmed: 31143177
J Immunother Cancer. 2019 Oct 17;7(1):264
pubmed: 31623662
Trends Immunol. 2016 Sep;37(9):597-607
pubmed: 27501916
J Exp Med. 1987 Aug 1;166(2):589-94
pubmed: 3110355
J Immunol. 2016 Aug 15;197(4):1287-97
pubmed: 27430718
Eur J Immunol. 1997 Dec;27(12):3182-90
pubmed: 9464804
Nature. 2019 Mar;567(7749):525-529
pubmed: 30814730
Clin Rev Allergy Immunol. 2019 Apr;56(2):219-233
pubmed: 30206782
Front Cell Infect Microbiol. 2018 Nov 27;8:417
pubmed: 30538956
Nat Immunol. 2013 Nov;14(11):1173-82
pubmed: 24076634
Sci Rep. 2017 May 17;7(1):1999
pubmed: 28515464
PLoS Pathog. 2015 Jan 29;11(1):e1004582
pubmed: 25632943
Eur J Immunol. 2013 Jun;43(6):1568-77
pubmed: 23456989
N Engl J Med. 2018 Oct 11;379(15):1403-1415
pubmed: 30280646
Sci Transl Med. 2014 Nov 19;6(263):263ra159
pubmed: 25411472
PLoS Pathog. 2016 May 31;12(5):e1005667
pubmed: 27244558
Nature. 2019 Dec;576(7786):293-300
pubmed: 31802004
Virulence. 2013 Jan 1;4(1):3-66
pubmed: 23076359
J Intern Med. 2018 Sep;284(3):292-306
pubmed: 29696707
Crit Care Med. 2016 Feb;44(2):275-81
pubmed: 26584195
Science. 2019 Nov 22;366(6468):1013-1021
pubmed: 31699883
Nat Rev Immunol. 2019 Mar;19(3):154-169
pubmed: 30622345
Nat Genet. 2018 Jun;50(6):849-856
pubmed: 29785015
Int J Tuberc Lung Dis. 2019 Jan 1;23(1):93-98
pubmed: 30674380
Expert Rev Anti Infect Ther. 2016;14(5):501-9
pubmed: 27042967
Lancet Respir Med. 2016 Mar;4(3):213-24
pubmed: 26907218
J Clin Invest. 2015 Jun;125(6):2347-62
pubmed: 25938788
Lancet Infect Dis. 2003 Mar;3(3):148-55
pubmed: 12614731
Lancet. 2004 Dec 11-17;364(9451):2113-21
pubmed: 15589309
Lancet Respir Med. 2017 Apr;5(4):282-290
pubmed: 28215501
J Clin Invest. 2010 Sep;120(9):3365-76
pubmed: 20679732
PLoS Pathog. 2015 Jul 02;11(7):e1005007
pubmed: 26133770
BMC Public Health. 2019 Jun 25;19(1):820
pubmed: 31238906
Nat Immunol. 2020 Mar;21(3):287-297
pubmed: 31932812
Cell. 2013 Apr 25;153(3):521-34
pubmed: 23582643
J Exp Med. 1984 Aug 1;160(2):521-40
pubmed: 6332167
Semin Immunol. 2013 Nov 15;25(4):313-20
pubmed: 24211041
Semin Immunol. 2014 Dec;26(6):543-51
pubmed: 25453229
J Immunol. 2011 Feb 1;186(3):1598-607
pubmed: 21172867
J Infect Dis. 2000 Mar;181(3):1194-7
pubmed: 10720554
Nat Rev Microbiol. 2018 Feb;16(2):80-90
pubmed: 29109555
J Immunol. 2003 Sep 15;171(6):3110-8
pubmed: 12960337
Immunity. 2016 Aug 16;45(2):374-88
pubmed: 27496732
Chest. 2017 Jul;152(1):165-173
pubmed: 28434936
Thorax. 2018 Apr 5;:
pubmed: 29622693
Nat Rev Immunol. 2009 May;9(5):377-84
pubmed: 19330016
J Immunol. 2014 Nov 1;193(9):4457-68
pubmed: 25246495
Nat Microbiol. 2018 Oct;3(10):1099-1108
pubmed: 30224802
Tuberculosis (Edinb). 2009 May;89(3):195-8
pubmed: 19345146
PLoS One. 2014 Mar 26;9(3):e92977
pubmed: 24671137
J Allergy Clin Immunol. 2011 Feb;127(2):355-60
pubmed: 21281866

Auteurs

Andrew R DiNardo (AR)

The Global Tuberculosis Program, Texas Children's Hospital, Immigrant and Global Health, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

Tomoki Nishiguchi (T)

The Global Tuberculosis Program, Texas Children's Hospital, Immigrant and Global Health, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

Sandra L Grimm (SL)

Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Molecular and Cellular Biology, Center for Precision Environmental Health, Baylor College of Medicine, Houston, TX, USA.

Larry S Schlesinger (LS)

Texas Biomedical Research Institute, San Antonio, TX, USA.

Edward A Graviss (EA)

Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, USA.

Jeffrey D Cirillo (JD)

Department of Microbial and Molecular Pathogenesis, Texas A&M College of Medicine, Bryan, TX, USA.

Cristian Coarfa (C)

Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Molecular and Cellular Biology, Center for Precision Environmental Health, Baylor College of Medicine, Houston, TX, USA.

Anna M Mandalakas (AM)

The Global Tuberculosis Program, Texas Children's Hospital, Immigrant and Global Health, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

Jan Heyckendorf (J)

Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
German Center for Infection Research (DZIF) Clinical Tuberculosis Unit, Borstel, Germany.
Respiratory Medicine & International Health, University of Lübeck, Lü beck, Germany.

Stefan H E Kaufmann (SHE)

Max Planck Institute for Infection Biology, Berlin, Germany.
Hagler Institute for Advanced Study, Texas A&M University, College Station, TX, USA.
Max Planck Institute for Biophysical Chemistry, Am Faßberg 11, 37077 Gö ttingen, Germany.

Christoph Lange (C)

Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
German Center for Infection Research (DZIF) Clinical Tuberculosis Unit, Borstel, Germany.
Respiratory Medicine & International Health, University of Lübeck, Lü beck, Germany.

Mihai G Netea (MG)

Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Immunology and Metabolism, Life & Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany.

Reinout Van Crevel (R)

Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH